TipRanks
Advertisement
Advertisement

AU:CHM Stock Latest News

Magellan exits substantial holding in Chimeric Therapeutics
Company AnnouncementsMagellan exits substantial holding in Chimeric Therapeutics
12d ago
CHM
Chimeric Therapeutics Discloses Final Director Interest as Lesley Russell Departs Board
PremiumCompany Announcements
Chimeric Therapeutics Discloses Final Director Interest as Lesley Russell Departs Board
15d ago
CHM
Chimeric Therapeutics Announces Departure of Director Without Shareholdings
PremiumCompany Announcements
Chimeric Therapeutics Announces Departure of Director Without Shareholdings
15d ago
CHM
Chimeric Therapeutics Names New Director, Grants 500,000 Options
PremiumCompany Announcements
Chimeric Therapeutics Names New Director, Grants 500,000 Options
15d ago
CHM
Chimeric Therapeutics Suspended as It Negotiates Creditor Deals and Board Restructure
PremiumCompany Announcements
Chimeric Therapeutics Suspended as It Negotiates Creditor Deals and Board Restructure
19d ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 29.3 Million New Shares
PremiumCompany AnnouncementsChimeric Therapeutics Seeks ASX Quotation for 29.3 Million New Shares
21d ago
CHM
Chimeric Therapeutics Seeks Quotation for 22.2 Million New Shares on ASX
Premium
Company Announcements
Chimeric Therapeutics Seeks Quotation for 22.2 Million New Shares on ASX
28d ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 14.8 Million New Shares
Premium
Company Announcements
Chimeric Therapeutics Seeks ASX Quotation for 14.8 Million New Shares
2M ago
CHM
Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities
PremiumCompany Announcements
Chimeric Therapeutics posts deeper loss as IP impairments push it into net liabilities
2M ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for 9.5 Million New Shares
2M ago
CHM
Chimeric Therapeutics Halts Trading Ahead of CDH17 Trial Results
PremiumCompany Announcements
Chimeric Therapeutics Halts Trading Ahead of CDH17 Trial Results
2M ago
CHM
Chimeric Therapeutics Seeks Quotation of 1.85 Million New Shares on ASX
PremiumCompany Announcements
Chimeric Therapeutics Seeks Quotation of 1.85 Million New Shares on ASX
2M ago
CHM
Chimeric Therapeutics Reports Positive Trial Data and Launches Strategic Review
PremiumCompany AnnouncementsChimeric Therapeutics Reports Positive Trial Data and Launches Strategic Review
3M ago
CHM
Chimeric Therapeutics Secures $1.62m R&D Tax Incentive Funding to Back Clinical Trials and Strategic Review
Premium
Company Announcements
Chimeric Therapeutics Secures $1.62m R&D Tax Incentive Funding to Back Clinical Trials and Strategic Review
3M ago
CHM
Chimeric Flags Clinical and Regulatory Risks in Forward-Looking Disclaimer
Premium
Company Announcements
Chimeric Flags Clinical and Regulatory Risks in Forward-Looking Disclaimer
3M ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 1.55m New Shares
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for 1.55m New Shares
3M ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for Additional Shares
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for Additional Shares
3M ago
CHM
Chimeric Therapeutics Reports Expiry of 45,000 Unexercised Options
PremiumCompany Announcements
Chimeric Therapeutics Reports Expiry of 45,000 Unexercised Options
3M ago
CHM
Chimeric Therapeutics Details Director Exit and Post-Consolidation Option Holdings
PremiumCompany Announcements
Chimeric Therapeutics Details Director Exit and Post-Consolidation Option Holdings
3M ago
CHM
Chimeric Therapeutics Board Member Eric Sullivan Retires
PremiumCompany AnnouncementsChimeric Therapeutics Board Member Eric Sullivan Retires
4M ago
CHM
Chimeric Therapeutics Seeks Quotation for 1.77 Million New ASX Shares
Premium
Company Announcements
Chimeric Therapeutics Seeks Quotation for 1.77 Million New ASX Shares
4M ago
CHM
Chimeric Therapeutics Launches Adviser-Led Strategic Review to Unlock Value
Premium
Company Announcements
Chimeric Therapeutics Launches Adviser-Led Strategic Review to Unlock Value
4M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >